Natera, Inc. vs Johnson & Johnson
NTRA vs JNJ — side-by-side comparison from reported financials. NTRA leads 3, JNJ leads 5 of 8 comparable metrics.
Natera, Inc.
NTRA · Healthcare
$400.71+2.54%Strained
Johnson & Johnson
JNJ · Healthcare
$261.79+2.07%Mixed
| Metric | NTRA | JNJ |
|---|---|---|
| Price | $400.71 | $261.79 |
| Market cap | $57.8B | $631B |
| Revenue (TTM) | $2.71B | $97.9B |
| Revenue growth | +41.1% | +5.6% |
| Net margin | -7.1% | 21.5% |
| Free cash flow | $84.2M | $22.2B |
| Net cash (debt) | $1.02B | ($27.8B) |
| 1-year price return | +131.6% | +37.0% |
| P/E | — | 29.9 |
| P/E vs own history (cheap-side %) | — | 16% |
| Dividend yield | — | 2.00% |
| Return on equity | -12% | 26% |
| CV checks passed | 4 of 9 | 10 of 9 |
| Employees | 6,140 | 140,800 |
Full résumé-style profiles: NTRA CV · JNJ CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.